These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20643554)

  • 1. Synthesis of aryl-heteroaryl ureas (AHUs) based on 4-aminoquinoline and their evaluation against the insulin-like growth factor receptor (IGF-1R).
    Engen W; O'Brien TE; Kelly B; Do J; Rillera L; Stapleton LK; Youngren JF; Anderson MO
    Bioorg Med Chem; 2010 Aug; 18(16):5995-6005. PubMed ID: 20643554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel synthesis of diarylureas and their evaluation as inhibitors of insulin-like growth factor receptor.
    Anderson MO; Yu H; Penaranda C; Maddux BA; Goldfine ID; Youngren JF; Guy RK
    J Comb Chem; 2006; 8(5):784-90. PubMed ID: 16961415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline.
    Casagrande M; Barteselli A; Basilico N; Parapini S; Taramelli D; Sparatore A
    Bioorg Med Chem; 2012 Oct; 20(19):5965-79. PubMed ID: 22917857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis.
    Tsushima H; Morimoto S; Fujishiro M; Yoshida Y; Hayakawa K; Hirai T; Miyashita T; Ikeda K; Yamaji K; Takamori K; Takasaki Y; Sekigawa I; Tamura N
    Autoimmunity; 2017 Aug; 50(5):329-335. PubMed ID: 28682648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor.
    Khalid S; Hanif R; Jabeen I; Mansoor Q; Ismail M
    PLoS One; 2018; 13(5):e0196312. PubMed ID: 29787591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab.
    Iyer G; Price J; Bourgeois S; Armstrong E; Huang S; Harari PM
    BMC Cancer; 2016 Oct; 16(1):773. PubMed ID: 27716204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage.
    Waraky A; Lin Y; Warsito D; Haglund F; Aleem E; Larsson O
    J Biol Chem; 2017 Nov; 292(44):18227-18239. PubMed ID: 28924044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase.
    Abouzid K; Shouman S
    Bioorg Med Chem; 2008 Aug; 16(16):7543-51. PubMed ID: 18678492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo.
    Doern A; Cao X; Sereno A; Reyes CL; Altshuler A; Huang F; Hession C; Flavier A; Favis M; Tran H; Ailor E; Levesque M; Murphy T; Berquist L; Tamraz S; Snipas T; Garber E; Shestowsky WS; Rennard R; Graff CP; Wu X; Snyder W; Cole L; Gregson D; Shields M; Ho SN; Reff ME; Glaser SM; Dong J; Demarest SJ; Hariharan K
    J Biol Chem; 2009 Apr; 284(15):10254-67. PubMed ID: 19211557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual treatments targeting IGF-1R, PI3K, mTORC or MEK synergize to inhibit cell growth, induce apoptosis, and arrest cell cycle at G1 phase in MDA-MB-231 cell line.
    Ayub A; Yip WK; Seow HF
    Biomed Pharmacother; 2015 Oct; 75():40-50. PubMed ID: 26463630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin growth factor-1 (IGF-1) enhances hippocampal excitatory and seizure activity through IGF-1 receptor-mediated mechanisms in the epileptic brain.
    Jiang G; Wang W; Cao Q; Gu J; Mi X; Wang K; Chen G; Wang X
    Clin Sci (Lond); 2015 Dec; 129(12):1047-60. PubMed ID: 26286172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclearly translocated insulin-like growth factor 1 receptor phosphorylates histone H3 at tyrosine 41 and induces SNAI2 expression via Brg1 chromatin remodeling protein.
    Warsito D; Lin Y; Gnirck AC; Sehat B; Larsson O
    Oncotarget; 2016 Jul; 7(27):42288-42302. PubMed ID: 27275536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin.
    O'Flanagan CH; O'Shea S; Lyons A; Fogarty FM; McCabe N; Kennedy RD; O'Connor R
    Oncotarget; 2016 Aug; 7(35):56826-56841. PubMed ID: 27472395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel N
    Qi B; Yang Y; He H; Yue X; Zhou Y; Zhou X; Chen Y; Liu M; Zhang A; Wei F
    Eur J Med Chem; 2018 Feb; 146():368-380. PubMed ID: 29407963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutual regulation between IGF-1R and IGFBP-3 in human corneal epithelial cells.
    Titone R; Zhu M; Robertson DM
    J Cell Physiol; 2019 Feb; 234(2):1426-1441. PubMed ID: 30078228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling.
    Sin STK; Li Y; Liu M; Ma S; Guan XY
    Gynecol Oncol; 2019 Jan; 152(1):185-193. PubMed ID: 30429055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
    Obr AE; Kumar S; Chang YJ; Bulatowicz JJ; Barnes BJ; Birge RB; Lazzarino DA; Gallagher E; LeRoith D; Wood TL
    Breast Cancer Res; 2018 Nov; 20(1):138. PubMed ID: 30458886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase.
    Thompson AM; Connolly CJ; Hamby JM; Boushelle S; Hartl BG; Amar AM; Kraker AJ; Driscoll DL; Steinkampf RW; Patmore SJ; Vincent PW; Roberts BJ; Elliott WL; Klohs W; Leopold WR; Showalter HD; Denny WA
    J Med Chem; 2000 Nov; 43(22):4200-11. PubMed ID: 11063616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FES-related tyrosine kinase activates the insulin-like growth factor-1 receptor at sites of cell adhesion.
    Stanicka J; Rieger L; O'Shea S; Cox O; Coleman M; O'Flanagan C; Addario B; McCabe N; Kennedy R; O'Connor R
    Oncogene; 2018 Jun; 37(23):3131-3150. PubMed ID: 29540831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-1 signaling is responsible for cathepsin G-induced aggregation of breast cancer MCF-7 cells.
    Morimoto-Kamata R; Yui S
    Cancer Sci; 2017 Aug; 108(8):1574-1583. PubMed ID: 28544544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.